Qualitative and quantitative assessment of stent restenosis by optical coherence tomography - Comparison between drug-eluting and bare-metal stents -

Circulation Journal

Volumn 77, Issue 3, 2013, Pages 652-660

  Nagoshi, Ryoji ^a   Shinke, Toshiro ^a   Otake, Hiromasa ^a   Shite, Junya ^a   Matsumoto, Daisuke ^a   Kawamori, Hiroyuki ^a   Nakagawa, Masayuki ^b   Kozuki, Amane ^a   Hariki, Hirotoshi ^a   Inoue, Takumi ^a   Ohsue, Tsuyoshi ^a   Taniguchi, Yu ^a   Iwasaki, Masamichi ^a   Nishio, Ryo ^a   Hiranuma, Noritoshi ^a   Konishi, Akihide ^a   Kinutani, Hiroto ^a   Miyoshi, Naoki ^a   Takaya, Tomofumi ^b   Yamada, Shinichiro ^b   Yasaka, Yoshinori ^b   Hayashi, Takatoshi ^b   Yokoyama, Mitsuhiro ^b   Kato, Hiroki ^c   Kadotani, Makoto ^c   Ohnishi, Yoshio ^c   Hirata, Ken ichi ^a   more..

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Himeji Cardiovascular Center   (Japan)

^c Kakogawa East City Hospital   (Japan)

Author keywords

Bare metal stents; Drug eluting stents; In stent restenosis; Optical coherence tomography

Indexed keywords

PACLITAXEL; RAPAMYCIN;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; BLOOD VESSEL REACTIVITY; COMPARATIVE STUDY; DRUG ELUTING STENT; FEMALE; HUMAN; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; NEOINTIMA; OBSERVATIONAL STUDY; OPTICAL COHERENCE TOMOGRAPHY; PATHOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; RETROSPECTIVE STUDY;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; MALE; METALS; MIDDLE AGED; NEOINTIMA; PACLITAXEL; RETROSPECTIVE STUDIES; SIROLIMUS; STENTS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 84874433334     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0610     Document Type: Article

References (35)

1. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, et al. Pathology of acute and chronic coronary stenting in humans. Circulation 1999; 99: 44-52.
2. Chung IM, Gold HK, Schwartz SM, Ikari Y, Reidy MA, Wight TN. Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol 2002; 40: 2072-2081.
3. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: Still important, still much to learn. J Am Coll Cardiol 2004; 44: 1373-1385.
4. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
5. Finn AV, Joner M, Nakazawa G, Kolodgie F, Newell J, John MC, et al. Pathological correlates of late drug-eluting stent thrombosis: Strut coverage as a marker of endothelialization. Circulation 2007; 115: 2435-2441.
6. Hao H, Ishibashi-Ueda H, Tsujimoto M, Ueda Y, Shite J, Gabbiani G, et al. Drug-eluting stent: Importance of clinico-pathological correlations. Circ J 2011; 75: 1548-1558.
7. van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten Hoor SL, van Leeuwen MA, et al. Drug-eluting stents show delayed healing: Paclitaxel more pronounced than sirolimus. Eur Heart J 2007; 28: 974-979.
8. Chieffo A, Foglieni C, Nodari RL, Briguori C, Sangiorgi G, Latib A, et al. Histopathology of clinical coronary restenosis in drug-eluting versus bare metal stents. Am J Cardiol 2009; 104: 1660-1667.
9. Mehran R, Dangas G, Abizaid AS, Mintz GS, Lansky AJ, Satler LF, et al. Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 1999; 100: 1872-1878.
10. Serruys PW, Degertekin M, Tanabe K, Russell ME, Guagliumi G, Webb J, et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: Serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 2004; 109: 627-633.
11. Ohlmann P, Mintz GS, Kim SW, Pichard AD, Satler LF, Kent KM, et al. Intravascular ultrasound findings in patients with restenosis of sirolimus-and paclitaxel-eluting stents. Int J Cardiol 2008; 125: 11-15.
12. Kang SJ, Mintz GS, Park DW, Lee SW, Kim YH, Whan Lee C, et al. Mechanisms of in-stent restenosis after drug-eluting stent implantation: Intravascular ultrasound analysis. Circ Cardiovasc Interv 2011; 4: 9-14.
13. Matsumoto D, Shite J, Shinke T, Otake H, Tanino Y, Ogasawara D, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: Evaluated by optical coherence tomography. Eur Heart J 2007; 28: 961-967.
14. Takano M, Inami S, Jang IK, Yamamoto M, Murakami D, Seimiya K, et al. Evaluation by optical coherence tomography of neointimal coverage of sirolimus-eluting stent three months after implantation. Am J Cardiol 2007; 99: 1033-1038.
15. Takano M, Yamamoto M, Xie Y, Murakami D, Inami S, Okamatsu K, et al. Serial long-term evaluation of neointimal stent coverage and thrombus after sirolimus-eluting stent implantation by use of coronary angioscopy. Heart 2007; 93: 1353-1356.
16. Gonzalo N, Serruys PW, Regar E. Optical coherence tomography: Clinical applications and the evaluation of DES. Minerva Cardioangiol 2008; 56: 511-525.
17. Gonzalo N, Barlis P, Serruys PW, Garcia-Garcia HM, Onuma Y, Ligthart J, et al. Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography. JACC Cardiovasc Interv 2009; 2: 445-452.
18. Otake H, Shite J, Shinke T, Miyoshi N, Kozuki A, Kawamori H, et al. Impact of stent platform of paclitaxel-eluting stents: Assessment of neointimal distribution on optical coherence tomography. Circ J 2012; 76: 1880-1888.
19. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J 2009; 158: 284-293.
20. Takano M, Xie Y, Murakami D, Inami S, Yamamoto M, Ohba T, et al. Various optical coherence tomographic findings in restenotic lesions after sirolimus-eluting stent implantation. Int J Cardiol 2009; 134: 263-265.
21. Yamamoto M, Takano M, Murakami D, Inami T, Kimata N, Inami S, et al. Optical coherence tomography analysis for restenosis of drugeluting stents. Int J Cardiol 2010; 146: 100-103.
22. Habara M, Terashima M, Nasu K, Kaneda H, Inoue K, Ito T, et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: An optical coherence tomography study. Circ Cardiovasc Interv 2011; 4: 232-238.
23. Bezerra HG, Costa MA, Guagliumi G, Rollins AM, Simon DI. Intracoronary optical coherence tomography: A comprehensive review clinical and research applications. JACC Cardiovasc Interv 2009; 2: 1035-1046.
24. Kume T, Akasaka T, Kawamoto T, Ogasawara Y, Watanabe N, Toyota E, et al. Assessment of coronary arterial thrombus by optical coherence tomography. Am J Cardiol 2006; 97: 1713-1717.
25. Xu C, Schmitt JM, Carlier SG, Virmani R. Characterization of atherosclerosis plaques by measuring both backscattering and attenuation coefficients in optical coherence tomography. J Biomed Opt 2008; 13: 034003.
26. Templin C, Meyer M, Muller MF, Djonov V, Hlushchuk R, Dimova I, et al. Coronary optical frequency domain imaging (OFDI) for in vivo evaluation of stent healing: Comparison with light and electron microscopy. Eur Heart J 2010; 31: 1792-1801.
27. Nakazawa G, Finn AV, Vorpahl M, Ladich ER, Kolodgie FD, Virmani R. Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus-and paclitaxel-eluting stents. J Am Coll Cardiol 2011; 57: 390-398.
28. Kubo T, Tanaka A, Kitabata H, Ino Y, Tanimoto T, Akasaka T. Application of optical coherence tomography in percutaneous coronary intervention. Circ J 2012; 76: 2076-2083.
29. Otake H, Shite J, Ikeno F, Shinke T, Teramoto T, Miyoshi N, et al. Evaluation of the peri-strut low intensity area following sirolimus-and paclitaxel-eluting stents implantation: Insights from an optical coherence tomography study in humans. Int J Cardiol 2010; 157: 38-42.
30. Teramoto T, Ikeno F, Otake H, Lyons JK, van Beusekom HM, Fearon WF, et al. Intriguing peri-strut low-intensity area detected by optical coherence tomography after coronary stent deployment. Circ J 2010; 74: 1257-1259.
31. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis. Catheter Cardiovasc Interv 2010; 75: 961-963.
32. Nakazawa G, Otsuka F, Nakano M, Vorpahl M, Yazdani SK, Ladich E, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol 2011; 57: 1314-1322.
33. Cosgrave J, Melzi G, Corbett S, Biondi-Zoccai GG, Babic R, Airoldi F, et al. Repeated drug-eluting stent implantation for drug-eluting stent restenosis: The same or a different stent. Am Heart J 2007; 153: 354-359.
34. Garg S, Smith K, Torguson R, Okabe T, Slottow TL, Steinberg DH, et al. Treatment of drug-eluting stent restenosis with the same versus different drug-eluting stent. Catheter Cardiovasc Interv 2007; 70: 9-14.
35. Steinberg DH, Gaglia MA Jr, Pinto Slottow TL, Roy P, Bonello L, De Labriolle A, et al. Outcome differences with the use of drugeluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents. Am J Cardiol 2009; 103: 491-495.